Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

Simple item page
dc.contributor.authorAgache I.
dc.contributor.authorAnnesi-Maesano I.
dc.contributor.authorBonertz A.
dc.contributor.authorBranca F.
dc.contributor.authorCant A.
dc.contributor.authorFras Z.
dc.contributor.authorIngenrieth F.
dc.contributor.authorNamazova-Baranova L.
dc.contributor.authorOdemyr M.
dc.contributor.authorSpanevello A.
dc.contributor.authorVieths S.
dc.contributor.authorYorgancioglu A.
dc.contributor.authorAlvaro-Lozano M.
dc.contributor.authorBarber Hernandez D.
dc.contributor.authorChivato T.
dc.contributor.authorDel Giacco S.
dc.contributor.authorDiamant Z.
dc.contributor.authorEguiluz-Gracia I.
dc.contributor.authorvan Wijk R.G.
dc.contributor.authorGevaert P.
dc.contributor.authorGraessel A.
dc.contributor.authorHellings P.
dc.contributor.authorHoffmann-Sommergruber K.
dc.contributor.authorJutel M.
dc.contributor.authorLau S.
dc.contributor.authorLauerma A.
dc.contributor.authorMaria Olaguibel J.
dc.contributor.authorO'Mahony L.
dc.contributor.authorOzdemir C.
dc.contributor.authorPalomares O.
dc.contributor.authorPfaar O.
dc.contributor.authorSastre J.
dc.contributor.authorScadding G.
dc.contributor.authorSchmidt-Weber C.
dc.contributor.authorSchmid-Grendelmeier P.
dc.contributor.authorShamji M.
dc.contributor.authorSkypala I.
dc.contributor.authorSpinola M.
dc.contributor.authorSpranger O.
dc.contributor.authorTorres M.
dc.contributor.authorVereda A.
dc.contributor.authorBonini S.
dc.date.accessioned2024-07-22T08:08:15Z
dc.date.available2024-07-22T08:08:15Z
dc.date.issued2019
dc.description.abstractThe European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics. © 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
dc.identifier.DOI-ID10.1111/all.13856
dc.identifier.issn01054538
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14320
dc.language.isoEnglish
dc.publisherBlackwell Publishing Ltd
dc.rightsAll Open Access; Bronze Open Access
dc.subjectAsthma
dc.subjectBig Data
dc.subjectBioengineering
dc.subjectCapital Financing
dc.subjectDisease Management
dc.subjectDrug Development
dc.subjectEnvironmental Health
dc.subjectEurope
dc.subjectHealth Policy
dc.subjectHumans
dc.subjectHypersensitivity
dc.subjectImplementation Science
dc.subjectInformation Technology
dc.subjectPatient Participation
dc.subjectResearch
dc.subjectTranslational Medical Research
dc.subjectallergic disease
dc.subjectArticle
dc.subjectasthma
dc.subjectbiomedical engineering
dc.subjectchronic respiratory tract disease
dc.subjectclinical immunology
dc.subjectdesensitization
dc.subjectenvironmental health
dc.subjecthealth care policy
dc.subjecthuman
dc.subjectimmune deficiency
dc.subjectinformation technology
dc.subjectmedical research
dc.subjectmedical specialist
dc.subjectpatient participation
dc.subjectpractice guideline
dc.subjectpriority journal
dc.subjectresearch priority
dc.subjecttranslational research
dc.subjectWorld Health Organization
dc.subjectasthma
dc.subjectbioengineering
dc.subjectdisease management
dc.subjectdrug development
dc.subjecteconomics
dc.subjectEurope
dc.subjectfinancial management
dc.subjecthypersensitivity
dc.subjectlegislation and jurisprudence
dc.subjectorganization and management
dc.subjectprocedures
dc.subjectresearch
dc.subjecttranslational research
dc.titlePrioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases
dc.typeArticle

Files

Collections

Scopus Koleksiyonu